Erdenheim, PA, United States of America

Wendy Eccles

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy Eccles. Retrieved from https://idiyas.com/inventor/wendy-eccles-2497rd7u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wendy Eccles - Innovator in Pharmaceutical Compounds

Introduction

Wendy Eccles is a notable inventor based in Erdenheim, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various diseases.

Latest Patents

Wendy Eccles holds 1 patent for her invention titled "Small molecular inhibitors of NF-κb inducing kinase." This invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds. The methods of using these compounds are envisaged to be useful for preventing or treating diseases such as cancer, inflammatory disorders, autoimmune disorders, immunodermatologic disorders, and metabolic disorders like obesity and diabetes.

Career Highlights

Throughout her career, Wendy has focused on innovative solutions in the pharmaceutical industry. Her work has the potential to impact the treatment of serious health conditions, showcasing her dedication to advancing medical science.

Collaborations

Wendy has collaborated with notable professionals in her field, including Michael D Hack and William M Jones. These partnerships have contributed to the development and refinement of her innovative compounds.

Conclusion

Wendy Eccles is a pioneering inventor whose work in pharmaceutical compounds demonstrates her commitment to addressing critical health challenges. Her contributions are poised to make a significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…